Augmentin Dosing for Septal Cellulitis
For septal cellulitis (preseptal cellulitis), use high-dose amoxicillin-clavulanate at 90 mg/kg/day of the amoxicillin component divided into 2 doses (maximum 4000 mg/day), given for 7-10 days. This dosing provides adequate coverage against the most common pathogens including Streptococcus pneumoniae, beta-lactamase producing Haemophilus influenzae, and Staphylococcus aureus (methicillin-susceptible).
Specific Dosing Recommendations
Standard High-Dose Regimen
- Dose: 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day of clavulanate, divided every 12 hours 1
- Maximum: 2 g per dose (4000 mg/day total) 1
- Duration: 7-10 days 2
Risk Factors Requiring High-Dose Therapy
High-dose amoxicillin-clavulanate is particularly indicated when the patient has 1:
- Age younger than 2 years
- Attendance at child care
- Recent antibiotic use (within 30 days)
- Moderate to severe illness presentation
Alternative for Mild Cases in Low-Risk Patients
For children ≥2 years without risk factors, standard-dose amoxicillin-clavulanate (45 mg/kg/day in 2 divided doses) may be considered 1, though high-dose therapy is generally preferred for orbital/periorbital infections given the potential for serious complications.
Formulation Considerations
Critical: Different Augmentin formulations contain varying amounts of clavulanate and are not interchangeable 3:
- Augmentin ES-600: 600 mg amoxicillin/42.9 mg clavulanate per 5 mL
- Standard 400 mg/5 mL suspension: 400 mg amoxicillin/57 mg clavulanate per 5 mL
- Standard 200 mg/5 mL suspension: 200 mg amoxicillin/28.5 mg clavulanate per 5 mL
The high-dose formulation (14:1 ratio) minimizes clavulanate-related gastrointestinal side effects while maximizing amoxicillin exposure 4.
Administration Guidelines
- Timing: Administer at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 3
- Storage: Must be refrigerated after reconstitution; stable for 10 days 3
- Preparation: Shake well before each use 3
When to Consider Parenteral Therapy
Switch to intravenous therapy if the patient exhibits 5, 6:
- Signs of systemic toxicity (temperature >38.5°C, heart rate >110 bpm)
- Rapid progression despite oral antibiotics
- Inability to tolerate oral medications
- Extension beyond wound margins >5 cm
- Concern for orbital (postseptal) involvement
For parenteral therapy, use ampicillin-sulbactam 100-200 mg/kg/day divided every 6 hours or ceftriaxone 50-100 mg/kg/day 7, 2.
MRSA Coverage Considerations
Recent evidence suggests decreasing use of empiric MRSA coverage for preseptal cellulitis 8. Add vancomycin or clindamycin only if:
- Purulent drainage is present
- Known MRSA colonization
- Recent MRSA infection
- Failure to respond to beta-lactam therapy after 48-72 hours 5
Clindamycin dosing: 30-40 mg/kg/day divided every 6-8 hours (maximum 40 mg/kg/day) 5.
Common Pitfalls
- Underdosing: Using standard-dose (45 mg/kg/day) instead of high-dose (90 mg/kg/day) in high-risk patients reduces efficacy against resistant S. pneumoniae 1
- Wrong formulation: Substituting standard Augmentin suspensions for ES-600 results in excessive clavulanate and increased diarrhea 3
- Inadequate duration: Stopping at 5 days is insufficient; minimum 7 days required 2
- Heat exposure: Improper storage in hot environments degrades the antibiotic, leading to treatment failure 9